Astrana Health (NASDAQ:ASTH – Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $1.28 to $1.52 for the period, compared to the consensus estimate of $1.60. The company issued revenue guidance of $1.65 billion to $1.85 billion, compared to the consensus revenue estimate of $1.76 billion.
Astrana Health Trading Down 1.0 %
Astrana Health stock traded down $0.39 during mid-day trading on Tuesday, hitting $37.93. 125,527 shares of the company’s stock were exchanged, compared to its average volume of 153,978. Astrana Health has a 1-year low of $28.86 and a 1-year high of $45.71. The business has a 50 day moving average price of $40.47. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.11 and a current ratio of 2.11. The firm has a market capitalization of $2.13 billion, a PE ratio of 29.14, a P/E/G ratio of 1.20 and a beta of 1.12.
Astrana Health (NASDAQ:ASTH – Get Free Report) last announced its earnings results on Tuesday, February 27th. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.09. Astrana Health had a return on equity of 11.52% and a net margin of 4.49%. The firm had revenue of $353.00 million during the quarter, compared to analysts’ expectations of $341.17 million. During the same quarter in the prior year, the business earned $0.02 earnings per share. The company’s revenue was up 20.0% on a year-over-year basis. As a group, research analysts predict that Astrana Health will post 1.65 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Read Our Latest Stock Report on Astrana Health
Astrana Health Company Profile
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
See Also
- Five stocks we like better than Astrana Health
- Upcoming IPO Stock Lockup Period, Explained
- Garmin Navigates to New Highs Driven By Wearables Trend
- What is Insider Trading? What You Can Learn from Insider Trading
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- What is a Special Dividend?
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.